Arizona recreational and medical marijuana sales both picked up slightly during October after a disappointing summer season, according to state data from the Department of Revenue. Arizona dispensaries sold $75.3 million in recreational cannabis and another $16.9 million in medical marijuana for a total of $92.2 million in sales for …
Tag: Investing
Report: Kansans registering as medical marijuana patients in Missouri
Despite the now-flourishing recreational marijuana market in Missouri, “thousands” of residents of neighboring Kansas have obtained medical marijuana patient registrations and are still actively making purchases from dispensaries, due in large part to Kansas’ ongoing prohibition of all types of cannabis. There are roughly 2,200 Kansas residents with Missouri medical …
Green Rebates finalizes acquisition of competitor
Washington state-based Green Rebates – which has a business model focused on locating energy rebates for cannabis growers – finalized the acquisition of competitor Seinergy this month, in a deal that “will create the largest dedicated energy rebate platform for cultivators,” it said in a press release. Terms of the …
Relmada halts depression drug trials, shifts focus to psilocybin program amid review
Relmada Therapeutics Inc. (Nasdaq: RLMD) will halt its Phase 3 studies of depression treatment REL-1017 following a data monitoring committee evaluation, sending the company searching for strategic alternatives. The late-stage biotechnology company will discontinue both the Reliance II and Relight Phase 3 studies while continuing development of REL-P11, its modified …